Summary
N 4-Behenoyl-β-D-arabinofuranosylcytosine (behenoyl ara-C, NSC 239336) enhanced che-motherapeutic activity against L1210 murine leukemia as compared with 1-β-D-arabino-furanosylcytosine (ara-C). Behenoyl ara-C was resistant to deamination by cytidine deaminase, which was supposed to be liable for inactivating ara-C in vivo. Behenoyl ara-C exerted chemotherapeutic activity when administered before implantation of leukemic cells, suggesting prolonged circulation in the body fluid. These two findings indicate that the resistance to the enzymatic deamination and hydrophobicity endowed by behenic residue were responsible for the enhanced chemotherapeutic activity of behenoyl ara-C. This idea was supported by the finding that ara-C encapsulated in liposome enhanced chemotherapeutic activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aoshima, M., Tsukagoshi, S., Sakurai, Y., Ohishi, J., Ishida, T., Kobayashi, H.: Antitumor activities of newly synthesized N 4-acyl-1-β-D-arabinofuranosylcytosine. Cancer Res. 37, 2481 (1977)
Gregoriadis, G.: Targeting of drugs. Nature 265, 407 (1977)
Kataoka, T., Williamson, J. R., Kinsky, S. C.: Release of maeromolecular markers (enzymes) from liposomes treated with antibody and complement. Biochim. Biophys. Acta 298, 158 (1973)
Kobayashi, T., Kataoka, T., Tsukagoshi, S., Sakurai, Y.: Enhancement of anti-tumor activity of 1-β-D-arabinofuranosylcytosine by encapsulation in liposomes. Int. J. Cancer 20, 581 (1977)
Mayhew, E., Papahadjopoulos, D., Rustum, Y. M., Dave, C.: Inhibition of tumor cell growth in vitro and in vivo by 1-β-D-arabinofuranosylcytosine entrapped within phospholipid vesicles. Cancer Res. 36, 4406 (1976)
Sessa, G., Weissman, G.: Incorporation of lysosyme into liposomes. J. Biol. Chem. 245, 3295 (1970)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kataoka, T., Sakurai, Y. (1980). Effect and Mode of Action of N4-Behenoyl-β-D-Arabinofuranosylcytosine. In: Carter, S.K., Sakurai, Y. (eds) New Anticancer Drugs. Recent Results in Cancer Research, vol 70. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81392-4_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-81392-4_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81394-8
Online ISBN: 978-3-642-81392-4
eBook Packages: Springer Book Archive